Cargando…

Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma

Oral cavity squamous cell carcinoma (OSCC) is a destructive disease with increasing incidence. OSCC is usually diagnosed at an advanced stage, which leads to poor outcomes of OSCC patients. Currently, there is a lack of biomarkers with sufficient effectiveness in early diagnosis of OSCC. To ameliora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsueh, Pei-Chun, Chang, Kai-Ping, Liu, Hao-Ping, Chiang, Wei-Fan, Chan, Xiu-Ya, Hung, Chu-Mi, Chu, Lichieh Julie, Wu, Chih-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659860/ https://www.ncbi.nlm.nih.gov/pubmed/36387116 http://dx.doi.org/10.3389/fonc.2022.968570

Ejemplares similares

Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
por: Tseng, Yi-Ju, et al.
Publicado: (2022)

Clinical Outcome of Minor Salivary Gland Cancers in the Oral Cavity: A Comparative Analysis With Squamous Cell Carcinomas of the Oral Cavity
por: Park, Song I, et al.
Publicado: (2020)

Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma
por: Yen, Wei-Chen, et al.
Publicado: (2022)

Anti-p53 Autoantibody Detection in Automatic Glass Capillary Immunoassay Platform for Screening of Oral Cavity Squamous Cell Carcinoma
por: Lin, Yen-Heng, et al.
Publicado: (2020)

Prediction Model of Distant Metastasis in Oral Cavity Squamous Cell Carcinoma With or Without Regional Lymphatic Metastasis
por: Lu, Hsueh-Ju, et al.
Publicado: (2022)

Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals
por: Liao, Chun-Ta, et al.
Publicado: (2022)

A tumor-associated autoantibody panel for the detection of non-small cell lung cancer
por: Cai, Ruijun, et al.
Publicado: (2022)

Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls
por: Lohavanichbutr, Pawadee, et al.
Publicado: (2018)

Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
por: Xu, Yu, et al.
Publicado: (2023)

Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma
por: Ishikawa, Shigeo, et al.
Publicado: (2022)

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
por: Xu, Leidi, et al.
Publicado: (2022)

An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma
por: Liao, Chun-Ta, et al.
Publicado: (2016)

Towards an Improved Pathological Node Classification for Prognostic Stratification of Patients With Oral Cavity Squamous Cell Carcinoma: Results From a Nationwide Registry Study
por: Kang, Chung-Jan, et al.
Publicado: (2022)

Combination Intensity Modulated Proton Therapy and Passive Scatter Boost for Rapidly Progressing Nasal Cavity Squamous Cell Carcinoma
por: Ng, Sweet Ping, et al.
Publicado: (2017)

Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer
por: Chang, Ya-Ting, et al.
Publicado: (2020)

Survival-Weighted Health Profiles in Patients Treated for Advanced Oral Cavity Squamous Cell Carcinoma
por: Tsai, Yao-Te, et al.
Publicado: (2021)

Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review
por: Baillie, Ranui, et al.
Publicado: (2017)

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer
por: He, Tianyu, et al.
Publicado: (2022)

Endoplasmic Reticulum Stress of Oral Squamous Cell Carcinoma Induces Immunosuppression of Neutrophils
por: Wu, Ching-Fang, et al.
Publicado: (2022)

Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension
por: Huang, Pei-Wei, et al.
Publicado: (2022)

Identification of potential salivary biomarker panels for oral squamous cell carcinoma
por: Jain, Anu, et al.
Publicado: (2021)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

Serum autoantibody profiling of oral squamous cell carcinoma patients reveals NUBP2 as a potential diagnostic marker
por: Abdulla, Riaz, et al.
Publicado: (2023)

Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer
por: Lin, Yu-Ching, et al.
Publicado: (2021)

ASC contributes to metastasis of oral cavity squamous cell carcinoma
por: Wu, Chi-Sheng, et al.
Publicado: (2016)

Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules
por: Huo, Yunli, et al.
Publicado: (2020)

A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma
por: Fang, Ku-Hao, et al.
Publicado: (2020)

Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
por: Yang, Pei-Wen, et al.
Publicado: (2019)

Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2021)

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer
por: Zhou, Juan, et al.
Publicado: (2021)

Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis
por: Wang, Ting, et al.
Publicado: (2021)

A circulating miRNA signature for early diagnosis of acute kidney injury following acute myocardial infarction
por: Fan, Pei-Chun, et al.
Publicado: (2019)

A 14-Marker Multiplexed Imaging Panel for Prognostic Biomarkers and Tumor Heterogeneity in Head and Neck Squamous Cell Carcinoma
por: Mitsuda, Junichi, et al.
Publicado: (2021)

Clinical impact of human papillomavirus in laryngeal squamous cell carcinoma: a retrospective study
por: Chen, Wei-Chih, et al.
Publicado: (2017)

Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor
por: Lin, Chiu-Min, et al.
Publicado: (2019)

Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study
por: Kazmi, Anum, et al.
Publicado: (2022)

Solitary Myocardial Metastasis from Locoregionally Controlled Squamous Cell Carcinoma of the Oral Cavity
por: Martell, Kevin, et al.
Publicado: (2016)

Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer
por: Hong, Chao-Qun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1v03vbkuppokld1lpobmggv260